Aldeyra Therapeutics, Inc. (ALDX) Covered Calls

You can sell covered calls on Aldeyra Therapeutics, Inc. to lower risk and earn monthly income. Born To Sell's covered call screener gives you customized search capabilities across all possible covered calls but here are a couple of examples for ALDX (prices last updated Thu 4:16 PM ET):

Aldeyra Therapeutics, Inc. (ALDX) Stock Quote
Last Change Bid Ask Volume P/E Market Cap
6.26 -0.04 6.25 6.51 1.4M - 0.4
Covered Calls For Aldeyra Therapeutics, Inc. (ALDX)
Expiration Strike Call Bid Net Debit Return
If Flat		 Annualized
Return If Flat
Apr 17 7.5 0.70 5.81 12.0% 199%
May 16 7.5 0.75 5.76 13.0% 93.0%
Subscribers get access to the full covered call chain, and more features.

Want to make money with covered calls?  Sign Up For A Free Trial

Extended Business Description

Aldeyra Therapeutics, Inc., a biotechnology company, focuses on the development of products for inflammation, inborn errors of metabolism, and other diseases in the United States and internationally. It is developing ADX-102, a small molecule designed to trap and allow for the degradation of aldehydes, as well as ADX-103 and ADX-104 novel candidates for the treatment of noninfectious anterior uveitis, allergic conjunctivitis, dry eye syndrome, sjˆgren-larsson syndrome, and succinic semi-aldehyde dehydrogenase deficiency. Aldeyra Therapeutics, Inc. has a collaborative research agreement with Janssen Research & Development, LLC for the development of novel immune-modulating drugs for systemic inflammatory diseases. The company was formerly known as Aldexa Therapeutics, Inc. and changed its name to Aldeyra Therapeutics, Inc. in March 2014. Aldeyra Therapeutics, Inc. was founded in 2004 and is headquartered in Lexington, Massachusetts.